Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by Rumpl3StiltSkinon Apr 25, 2022 11:27am
247 Views
Post# 34629025

RE:RE:RE:RE:RE:RE:RE:RE:RE:BTD timeline...

RE:RE:RE:RE:RE:RE:RE:RE:RE:BTD timeline...Laser,

Now that Vera, Dr. Rad! is on board that is her job. I have no reason to doubt her ability. I think BTD is what gets SP to turn the corner, stop any shorter nonsense, etc... The data didn't appear to quite be there in the last PR, I'd be very surprised if the next PR doesn't verify BTD, or at least let us know where it is??

LaserStock29 wrote: Again the question is if we get BTD asap  what is the PPS? 

Has Theralase used the Fast Track to establish a Rolling Review submission and dialog with FDA so it doesn't have to act like a company that would just submit all the data as one package.. but can have back and forth this whole time as data comes in?

When do we get to $1-2...... when the whole thing is over? 

Rumpl3StiltSkin wrote: FGP,

I believe the timeline of early 2023 was prior to Delta and Omicron, backing things up..?? Still, I expect they'll have AA by Middle of 2023.

FGPstock wrote:
Eog, Theralase has given us timelines before, but can you point to a recent statement from the company saying commercialazation in early 2023. Even if they received BTD tomorrow, that is still an agressive timeline, imo... Not sure why either the company and/or their analyst could lay the data a bit more clearly. Weren't they meantioned they were going to apply for BTD after 20-25 patients?

 




<< Previous
Bullboard Posts
Next >>